Evaluation of the Intestinal Microbiome in Obese Children With and Without Non-Alcoholic Fatty Liver Disease

Status: Withdrawn
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this study is to investigate comparisons between the intestinal microbiome in patients with obesity and in patients with obesity and Non-Alcoholic Fatty Liver Disease (NAFLD). With this protocol we hope to better understand how the microbiome of each individual works with disease progression.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 18
Healthy Volunteers: No
View:

• Age 5-18 Years old

• Willing to consent/undergo necessary procedures

• Obese (BMI>30)

• Speak English or Spanish

Locations
United States
Wisconsin
Children's Hospital of Wisconsin
Milwaukee
Time Frame
Start Date: October 2008
Completion Date: October 2012
Treatments
Controls
Obese (BMI>30) and normal AST and ALT. Between the ages of 5 and 18 years old.
Liver Disease
Obese (BMI>30) and elevated AST and/or ALT (evidence of NAFLD). Between the ages of 5 and 18 years old.
Sponsors
Leads: Medical College of Wisconsin

This content was sourced from clinicaltrials.gov

Similar Clinical Trials